Cardio-autonomic functions and sleep indices before and after coronary artery bypass surgery

Khamis Mohammed Al-Hashmi1, Mohammed A Al-Abri2, Deepali S Jaju2

  • 1Department of Physiology, College of Medicine and Health Sciences, Sultan Qaboos University, Al Khoud, Muscat, Sultanate of Oman.

Insights

Coronary artery bypass grafting (CABG) surgery showed early recovery of cardio-autonomic functions within 30 days. This study found no significant short-term impact of CABG on obstructive sleep apnea (OSA) indices in patients with ischemic heart disease.

Area of Science:

  • Cardiology
  • Sleep Medicine
  • Autonomic Neuroscience

Background:

  • Coronary artery bypass grafting (CABG) may impair cardio-autonomic function short-term.
  • Recovery timelines post-CABG vary, with limited data on obstructive sleep apnea (OSA) influence.
  • Objective sleep assessment is often lacking in studies linking post-CABG atrial fibrillation to OSA.

Purpose of the Study:

  • To assess the impact of CABG on cardio-autonomic, hemodynamic, and OSA indices in patients with ischemic heart disease (IHD).
  • To determine the recovery trajectory of these functions post-CABG.

Main Methods:

  • Evaluated 26 stable IHD patients undergoing CABG.
  • Measured heart rate variability (HRV) indices, hemodynamic parameters, and sleep study data preoperatively, on day 6, and day 30 post-CABG.

Main Results:

  • High-frequency HRV powers significantly increased by day 6 post-CABG (P=0.002), indicating improved parasympathetic activity.
  • Low-frequency HRV powers significantly decreased by day 6 (P=0.002), suggesting reduced sympathetic activity.
  • No significant changes were observed in baroreceptor sensitivity, OSA indices, or oxygen saturation levels at any assessment point.

Conclusions:

  • Autonomic function recovery post-CABG can occur as early as 30 days.
  • CABG does not appear to significantly affect sleep study indices in the short term.
  • Long-term effects of CABG on these parameters require further investigation.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
553
Indicators02:39

Indicators

Certain organic substances change color in dilute solution when the hydronium ion concentration reaches a particular value. For example, phenolphthalein is a colorless substance in any aqueous solution with a hydronium ion concentration greater than 5.0 × 10−9 M (pH < 8.3). In more basic solutions where the hydronium ion concentration is less than 5.0 × 10−9 M (pH > 8.3), it is red or pink. Substances such as phenolphthalein, which can be used to determine the pH of a solution, are...
61.2K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
303
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
424
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
736